IMMUNOCHROMATOGRAPHIC RAPID SEROLOGICAL TEST
for the qualitative detection of IgM and IgG specific for SARS-CoV-2 virus (COVID-19) from a drop of blood.
SPEED
A result in a few minutes, no transport of the biological sample to a laboratory, easy to read results.
RELIABILITY
Detection on the same test of anti-SARS-CoV-2 IgM and IgG (detection of specific anti-SARS-CoV-2 antibodies). Concordance with the reference technique (RT PCR), the clinical pictures and the serological windows expected for this type of test. Positive Predictive Value of the 100% test.
EASY TO USE
The test is for single use, easy to use by the entire medical profession and does not require any additional equipment: 2 formats available, an "All in One" incorporating lancet and blood collector and a cassette format with all the capillary blood collection elements supplied in the kit, for maximum safety and practicality.
PATIENT COMFORT
Non-painful test, taking a single drop of blood at the fingertip (nasopharyngeal swabs can be perceived as anxiety-provoking and unpleasant by patients and require trained personnel to be performed correctly).
NG-TEST® IgG-IgM COVID-19 indicates the patient's immune status by detecting virus-specific IgM and IgG. This knowledge of the immune status of those tested could also allow them to better adapt and organize themselves if new episodes come.
Imaging exams, molecular, antigenic and serological tests are complementary and can allow better identification of patients with the virus, know their immune status and therefore improve their care and management of the epidemic.
In order to participate in and support the collective effort to fight the COVID-19 pandemic, the company NG Biotech offers serological tests intended for screening and monitoring the immune status of people potentially infected with the virus.
NG Biotech is a family company, specialized in rapid biological analysis tests, mobile and connected. It designs and manufactures innovative solutions to meet different needs: responding to medical emergencies, in the laboratory or at the bedside. Founded in 2012, NG Biotech has been able to gain a place and a reputation in several fields in several years, in particular in the field of bacteriology with the rapid detection of bacteria resistant to antibiotics, and in the field of women's health with pregnancy tests from a drop of blood. These tests are available in more than 70 countries, including the United States.
Located in Brittany, NG Biotech has a complete structure with an R&D laboratory and two production units that comply with international quality standards.
NG Biotech is primarily positioned to provide support and expertise in various major public health issues.
